Whole-Course Application of Dexmedetomidine Combined with Ketorolac in Nonnarcotic Postoperative Analgesia for Patients with Lung Cancer Undergoing Thoracoscopic Surgery: A Randomized Control Trial

被引:5
作者
Wen, Qing-ping [1 ]
Miao, Zhuang [1 ]
Wu, Ping [1 ]
Wang, Jing [2 ]
Zhou, Fa-chen [3 ]
Lin, Yun [2 ]
Lu, Xin-yu [1 ]
Lv, Run [2 ]
Hou, Qian-hao [2 ]
机构
[1] Dalian Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Dalian, Peoples R China
[2] Dalian Med Univ, Anesthesiol Dept, Dalian, Peoples R China
[3] Dalian Med Univ, Dept Thorac Surg, Affiliated Hosp 1, Dalian, Peoples R China
关键词
Dexmedetomidine; ketorolac; sufentanil; thoracoscopic surgery; postoperative analgesic; patient-controlled analgesia; inflammatory response; immune function; CYTOKINE LEVELS; CELLS; PAIN; ANESTHESIA;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Opioid-based postoperative analgesia provides adequate analgesia with much adverse effects and immunosuppression. Dexmedetomidine and ketorolac have properties of opioid-sparing, antiinflammation, and immune protection. Objectives: To investigate the efficacy and safety of whole-course application of dexmedetomidine combined with ketorolac in nonnarcotic postoperative analgesia and its effect on inflammatory response and immune function in thoracoscopic surgery of lung cancer. Study Design: Double-blind, randomized control trial. Setting: The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China. Methods: Sixty patients scheduled for thoracoscopic surgery were enrolled and randomly divided into 2 groups to receive a combination of intraoperative usage of dexmedetomidine and postoperative patient-controlled intravenous analgesia of dexmedetomidine 0.1 mu g/kg/h and ketorolac 3 mg/kg (DEX group) or only postoperative patient-controlled intravenous analgesia of sufentanil 1.5 mu g/kg and ketorolac 3 mg/kg (SUF group) for 48 hours. Vital signs, postoperative Visual Analog Scale (VAS) score, Ramsay sedation score, patient-controlled analgesia pressing times, consumption of sufentanil and rescue drug, and complications were compared between the 2 groups. The levels of inflammatory factors and immune function were also compared. Results: A significant reduction in median blood pressures and heart rates within 48 hours after surgery and perioperative consumption of sufentanil were observed in the DEX group compared with the SUF group (P < 0.05). No statistically significant difference was found in VAS scores, patient-controlled analgesia pressing times, and rescue drug consumption between the 2 groups (P > 0.05). The incidence of nausea was significantly lower in the DEX group compared with the SUF group (P< 0.05). A significant decrease of interleukin (IL)-1 beta, IL-6, tumor necrosis factor (INF)-alpha, and increased CD4(+) and CD4(+)/CD8(+) were observed in the DEX group compared with the SUF group at 24 and 48 hours after surgery (P< 0.05). There was no difference in the levels of CD8(+) and natural killer cells between the 2 groups (P> 0.05). Limitations: This study was limited by its sample size. Conclusions: Whole-course application of dexmedetomidine combined with ketorolac in nonnarcotic postoperative analgesia provided adequate and safe postoperative analgesia, reduced sufentanil consumption, analgesia-related complications, alleviated inflammatory response, and immunosuppression compared with sufentanil-based analgesia in thoracoscopic surgery.
引用
收藏
页码:E185 / E193
页数:9
相关论文
共 30 条
[1]   Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells [J].
Bernabe, Daniel G. ;
Tamae, Adriano C. ;
Biasoli, Eder R. ;
Oliveira, Sandra H. P. .
BRAIN BEHAVIOR AND IMMUNITY, 2011, 25 (03) :574-583
[2]   A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection [J].
Cata, Juan P. ;
Keerty, Visesh ;
Keerty, Dinesh ;
Feng, Lei ;
Norman, Peter H. ;
Gottumukkala, Vijaya ;
Mehran, John R. ;
Engle, Mitchel .
CANCER MEDICINE, 2014, 3 (04) :900-908
[3]   Effects of surgery, general anesthesia, and perioperative epidural analgesia on the immune function of patients with non-small cell lung cancer [J].
Cata, Juan P. ;
Bauer, Maria ;
Sokari, Telemate ;
Ramirez, Maria F. ;
Mason, David ;
Plautz, Gregory ;
Kurz, Andrea .
JOURNAL OF CLINICAL ANESTHESIA, 2013, 25 (04) :255-262
[4]   The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study [J].
Dong, Chun-Shan ;
Lu, Yao ;
Zhang, Jun ;
Sun, Peng ;
Yu, Jun-Ma ;
Wu, Chao ;
Lu, Qiang .
MEDICINE, 2016, 95 (39)
[5]   Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma [J].
Feng, Qinghua ;
Wei, Huafeng ;
Morihara, Janice ;
Stern, Joshua ;
Yu, Mujun ;
Kiviat, Nancy ;
Hellstrom, Ingegerd ;
Hellstrom, Karl Erik .
GYNECOLOGIC ONCOLOGY, 2012, 127 (02) :412-419
[6]   CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative [J].
Ghiringhelli, F ;
Larmonier, N ;
Schmitt, E ;
Parcellier, A ;
Cathelin, D ;
Garrido, C ;
Chauffert, B ;
Solary, E ;
Bonnotte, B ;
Martin, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) :336-344
[7]  
Gong L, 2014, INT J CLIN EXP PATHO, V7, P7708
[8]   Immune suppression while awaiting surgery and following it: Dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity [J].
Greenfeld, Keren ;
Avraham, Roi ;
Benish, Marganit ;
Goldfarb, Yael ;
Rosenne, Ella ;
Shapira, Yoram ;
Rudich, Tzvia ;
Ben-Eliyahu, Shamgar .
BRAIN BEHAVIOR AND IMMUNITY, 2007, 21 (04) :503-513
[9]  
Guo Yuan-Bo, 2017, Nan Fang Yi Ke Da Xue Xue Bao, V37, P1673
[10]   Continuous Infusion Nonsteroidal Anti-Inflammatory Drugs for Perioperative Pain Management [J].
Howard, Meredith L. ;
Isaacs, Alex N. ;
Nisly, Sarah A. .
JOURNAL OF PHARMACY PRACTICE, 2018, 31 (01) :66-81